SB
Insider selling
Sean Brynjelsen sold $6.1M of Eton Pharmaceuticals, Inc. (ETON) stock
Sean Brynjelsen, President & CEO of Eton Pharmaceuticals, Inc. (ETON), sold 100,000 shares of ETON stock worth $6.1M, per an SEC Form 4 filed Aug 20, 2026.
It was an open-market sale.
The trade happened on Aug 19, 2026, 1 day before it was made public.
ETON has moved -10.0% since the trade date, from $61.48 to $55.31 (Sep 21, 2026 close).
- Traded
- Aug 19, 2026
- Disclosed
- Aug 20, 2026
- Filing delay
- 1 day
- Price since
- -10.0%
- Role
- President & CEO
- Source
- SEC Form 4
More ETON insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.